Trial intelligence / Profile preview

Double-blind randomized placebo-controlled trial of levetiracetam for central neuropathic pain in multiple sclerosis

2006-000397-71Phase 4Completed

Sponsor: SÃ¸ren H. Sindrup, Department of Neurology, Odense University Hospital
Start: May 2006
Modality: Small Molecules
Countries: 1

Overview

Phase 4, randomised, double-blind trial in central neuropathic pain (CNP) and multiple sclerosis (MS) comparing levetiracetam with placebo (2 arms). Primary endpoint: Verbal pain relief score at end of treatment period. Started May 2006; status: completed.

Drugs

levetiracetam

Conditions

central neuropathic pain (CNP)multiple sclerosis (MS)

Beyond the preview

Go deeper on 2006-000397-71.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-000397-71.